Table 3.
Endothelial factors of different treatment (mean ± SD) (n = 8, each)
| YXC (g/kg) | Swimming (h) | NO (pg/ml) | ET (pg/ml) | TXB 2 (pg/ml) | 6-keto-PGF 1α (pg/ml) | ||||
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 16.80 ± 3.99 | 69.54 ± 9.58 | 361.91 ± 56.38 | 57.08 ± 12.57 | ||||
| 0 | 0.5 | 22.67 ± 4.28 | 60.32 ± 9.99 | 207.85 ± 66.03 | 84.86 ± 32.33 | ||||
| 0 | 1 | 24.38 ± 4.47 | 66.04 ± 8.25 | 326.70 ± 155.64 | 78.76 ± 31.82 | ||||
| 1 | 0 | 40.38 ± 7.61 | 73.21 ± 5.25 | 531.44 ± 126.99 | 65.84 ± 25.92 | ||||
| 1 | 0.5 | 32.00 ± 9.56 | 60.21 ± 5.13 | 167.76 ± 86.16 | 63.27 ± 16.27 | ||||
| 1 | 1 | 33.07 ± 8.07 | 65.16 ± 9.22 | 345.63 ± 139.01 | 69.27 ± 17.32 | ||||
| 2 | 0 | 39.62 ± 6.61 | 53.55 ± 8.82 | 362.03 ± 76.92 | 105.91 ± 28.86 | ||||
| 2 | 0.5 | 42.29 ± 12.83 | 62.75 ± 6.91 | 385.41 ± 157.32 | 85.35 ± 16.71 | ||||
| 2 | 1 | 36.19 ± 6.51 | 64.14 ± 8.30 | 212.34 ± 90.98 | 45.26 ± 17.28 | ||||
| Two-way ANOVA | F | P | F | P | F | P | F | P | |
| YXC | 37.361 | 0.000 | 3.642 | 0.330 | 0.778 | 0.466 | 1.544 | 0.224 | |
| Swimming | 0.162 | 0.851 | 1.868 | 0.164 | 8.018 | 0.001 | 2.150 | 0.127 | |
| YXC × Swimming | 3.142 | 0.020 | 4.418 | 0.004 | 5.479 | 0.001 | 6.322 | 0.001 | |
All data are expressed as the mean ± SD. The GLM procedure was applied for a two-way ANOVA to test for synergism effect. Comparisons between each pair of factor levels were analyzed using a Bonferon post hoc test. A value of P < 0.05 was considered statistically significant.